The Problem with OZEMPIC

OZEMPIC, a diabetes drug, is being widely accepted, despite skepticism towards other new pharma products. The core mistake of OZEMPIC is that obesity is not an OZEMPIC deficiency but a result of underlying metabolic dysfunction. The prevalence of obesity is rising due to environmental factors, such as the corrupt guidelines set by the USDA and agricultural subsidies for highly processed food. The US government pays over $10 billion per year from the federal treasury to soda companies through the food stamp program, further exacerbating the metabolic health crisis. Instead of addressing the root cause, OZEMPIC is being promoted as a solution for obesity, while pharmaceutical companies profit from the trillions of government funding invested in the drug. However, OZEMPIC has several problems, including gastrointestinal issues, stomach paralysis, and potential links to increased depression and suicidal ideation. Even when individuals receive government or insurance funding for the drug, many go off it within three months due to its side effects, resulting in weight gain. The European Union has launched an investigation into the drug's possible side effects and suicidal ideation. OZEMPIC's popularity is supported by corruption, with pharma companies paying off medical groups, doctors, academics, and even civil rights organizations to promote the drug.